United States (US) Cancer Therapy Market (2025-2031) | Companies, Value, Segmentation, Trends, Growth, Size & Revenue, Analysis, Industry, Outlook, Competitive Landscape, Share, Forecast

Market Forecast By Treatment Type (Chemotherapy, Target Therapy, Immunotherapy, Hormone Therapy, Other Treatment Types), By Cancer Type (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Respiratory/Lung Cancer, Other Cancer Types), By End User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Center) And Competitive Landscape
Product Code: ETC9961630 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Sumit Sagar No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Cancer Therapy Market Outlook
  • Market Size of United States (US) Cancer Therapy Market, 2024
  • Forecast of United States (US) Cancer Therapy Market, 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Revenues & Volume for the Period 2021- 2031
  • United States (US) Cancer Therapy Market Trend Evolution
  • United States (US) Cancer Therapy Market Drivers and Challenges
  • United States (US) Cancer Therapy Price Trends
  • United States (US) Cancer Therapy Porter's Five Forces
  • United States (US) Cancer Therapy Industry Life Cycle
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Treatment Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Chemotherapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Target Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Immunotherapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Hormone Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Other Treatment Types for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Cancer Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Blood Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Prostate Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Gastrointestinal Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Gynecologic Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Respiratory/Lung Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Other Cancer Types for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By End User for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Cancer Therapy Market Revenues & Volume By Cancer and Radiation Therapy Center for the Period 2021- 2031
  • United States (US) Cancer Therapy Import Export Trade Statistics
  • Market Opportunity Assessment By Treatment Type
  • Market Opportunity Assessment By Cancer Type
  • Market Opportunity Assessment By End User
  • United States (US) Cancer Therapy Top Companies Market Share
  • United States (US) Cancer Therapy Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Cancer Therapy Company Profiles
  • United States (US) Cancer Therapy Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Cancer Therapy Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Cancer Therapy Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Cancer Therapy Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Cancer Therapy Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Cancer Therapy Market - Industry Life Cycle

3.4 United States (US) Cancer Therapy Market - Porter's Five Forces

3.5 United States (US) Cancer Therapy Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F

3.6 United States (US) Cancer Therapy Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.7 United States (US) Cancer Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F

4 United States (US) Cancer Therapy Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in the US

4.2.2 Technological advancements in cancer therapy

4.2.3 Rising demand for personalized and targeted therapies

4.2.4 Growing investments in research and development for cancer treatments

4.3 Market Restraints

4.3.1 High cost of cancer therapies and treatments

4.3.2 Stringent regulatory requirements for approval of new therapies

4.3.3 Limited access to advanced cancer therapies in certain regions

4.3.4 Increasing concerns about the side effects of cancer treatments

5 United States (US) Cancer Therapy Market Trends

6 United States (US) Cancer Therapy Market, By Types

6.1 United States (US) Cancer Therapy Market, By Treatment Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Cancer Therapy Market Revenues & Volume, By Treatment Type, 2021- 2031F

6.1.3 United States (US) Cancer Therapy Market Revenues & Volume, By Chemotherapy, 2021- 2031F

6.1.4 United States (US) Cancer Therapy Market Revenues & Volume, By Target Therapy, 2021- 2031F

6.1.5 United States (US) Cancer Therapy Market Revenues & Volume, By Immunotherapy, 2021- 2031F

6.1.6 United States (US) Cancer Therapy Market Revenues & Volume, By Hormone Therapy, 2021- 2031F

6.1.7 United States (US) Cancer Therapy Market Revenues & Volume, By Other Treatment Types, 2021- 2031F

6.2 United States (US) Cancer Therapy Market, By Cancer Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Cancer Therapy Market Revenues & Volume, By Blood Cancer, 2021- 2031F

6.2.3 United States (US) Cancer Therapy Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.2.4 United States (US) Cancer Therapy Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.2.5 United States (US) Cancer Therapy Market Revenues & Volume, By Gastrointestinal Cancer, 2021- 2031F

6.2.6 United States (US) Cancer Therapy Market Revenues & Volume, By Gynecologic Cancer, 2021- 2031F

6.2.7 United States (US) Cancer Therapy Market Revenues & Volume, By Respiratory/Lung Cancer, 2021- 2031F

6.3 United States (US) Cancer Therapy Market, By End User

6.3.1 Overview and Analysis

6.3.2 United States (US) Cancer Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 United States (US) Cancer Therapy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.3.4 United States (US) Cancer Therapy Market Revenues & Volume, By Cancer and Radiation Therapy Center, 2021- 2031F

7 United States (US) Cancer Therapy Market Import-Export Trade Statistics

7.1 United States (US) Cancer Therapy Market Export to Major Countries

7.2 United States (US) Cancer Therapy Market Imports from Major Countries

8 United States (US) Cancer Therapy Market Key Performance Indicators

8.1 Patient survival rates post-cancer therapy

8.2 Adoption rates of innovative cancer therapies

8.3 Number of clinical trials for cancer treatments

8.4 Rate of approval for new cancer therapies

8.5 Patient satisfaction and quality of life post-cancer therapy

9 United States (US) Cancer Therapy Market - Opportunity Assessment

9.1 United States (US) Cancer Therapy Market Opportunity Assessment, By Treatment Type, 2021 & 2031F

9.2 United States (US) Cancer Therapy Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.3 United States (US) Cancer Therapy Market Opportunity Assessment, By End User, 2021 & 2031F

10 United States (US) Cancer Therapy Market - Competitive Landscape

10.1 United States (US) Cancer Therapy Market Revenue Share, By Companies, 2024

10.2 United States (US) Cancer Therapy Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Leadership Perspectives from Industry Events

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Industry Events and Analyst Meet

Whitepaper

Read All